ACCOFIL

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Tunisia, United Kingdom

Active ingredients

The drug ACCOFIL contains one active pharmaceutical ingredient (API):

1 Filgrastim
UNII PVI5M0M1GW - FILGRASTIM

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.

Read about Filgrastim

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ACCOFIL Solution for injection / infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AA02 Filgrastim L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 10914422, 10914439, 12566971, 12566988, 15200124, 15200130, 15203269, 15203275, 15561980, 15569102, 15569119, 15735693, 15735701, 15747035, 15747041, 16004000, 16004017, 16584641, 16584670, 16659557, 16659563, 16659586, 16659592, 16708066, 16708126, 16782890, 16783139, 16884231, 16884248, 17524144, 17524150
Country: EE Ravimiamet Identifier(s): 1664849, 1664850, 1664861, 1664872, 1706363, 1706374, 1706396, 1706408, 1735837, 1735848, 1887767, 1887778, 1887789, 1887790, 1887802
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 114946005, 114946008, 114946011, 114946014
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 534589, 569876
Country: FR Base de données publique des médicaments Identifier(s): 60812344, 68056062
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 289864, 289874, 393475, 393481
Country: IE Health Products Regulatory Authority Identifier(s): 88568, 88569
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8438, 8439
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1074505, 1074506, 1074507, 1074508, 1076199, 1076200, 1076201, 1076202, 1076203, 1076204, 1076205, 1076206, 1076207, 1076208, 1076209, 1076210, 1079880, 1079881, 1093024, 1093025, 1093026, 1093027, 1093028, 1093029, 1093030, 1093031, 1093032, 1093033, 1093034, 1093035, 1093036, 1093037, 1093038, 1093039, 1093040, 1093041
Country: NL Z-Index G-Standaard Identifier(s): 14165082
Country: NL Z-Index G-Standaard, PRK Identifier(s): 41831, 41858
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100327318, 100327324
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65658001, W65658002, W65659001, W65659002, W67882001, W67883001
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 16923101H, 16923102H

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.